Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Barnes E., Folgori A., Capone S., Swadling L., Aston S., Kurioka A., Meyer J., Huddart R., Smith K., Townsend R., Brown A., Antrobus R., Ammendola V., Naddeo M., O’Hara G., Willberg C., Harrison A., Grazioli F., Esposito ML., Siani L., Traboni C., Oo Y., Adams D., Hill A., Colloca S., Nicosia A., Cortese R., Klenerman P.
An adenoviral HCV vaccine induces antiviral T cell responses in human volunteers.